Company intelligence / Profile preview
PrecisionBiotics
- Ownership
- Private
- Development stage
- Other
Overview
Multiple proprietary probiotic strains have demonstrated clinical efficacy in managing IBS symptoms, improving stress resilience and anxiety reduction, supporting vaginal health, with additional preclinical data in immune support. Products are validated by robust clinical studies primarily in the UK and Europe.
- Therapeutic areas
- Infectious DiseasesPsychiatryGastroenterologyWomen's Health
- Modalities
- Live biotherapeutic product therapy (probiotics)Microbial therapy
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on PrecisionBiotics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PrecisionBiotics.